Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-α transgenic mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Hopkins, Teresa A ^a   Sugden, Mary C ^b   Holness, Mark J ^b   Kozak, Ray ^a   Dyck, Jason R B ^a   Lopaschuk, Gary D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Fatty acid oxidation; Glucose oxidation; Pyruvate dehydrogenase kinase

Indexed keywords

FATTY ACID; HEART ENZYME; ISOENZYME; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PHOSPHOTRANSFERASE; PIRINIXIC ACID; PYRUVATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE KINASE; PYRUVATE DEHYDROGENASE KINASE 1; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID OXIDATION; GENE OVEREXPRESSION; GLUCOSE OXIDATION; HEART MUSCLE METABOLISM; ISOLATED HEART; MALE; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE;

EID: 0038000660     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00852.2002     Document Type: Article

References (32)

1. Aasum E, Belke DD, Severson DL, Riemersma RA, Cooper M, Andreassen M, and Larsen TS. Cardiac function and metabolism in Type 2 diabetic mice after treatment with BM 17.0744, a novel PPAR-α activator. Am J Physiol Heart Circ Physiol 283: H949-H957, 2002.
2. Aoyama T, Peters JM, Iritani N, Nakajima T, Furihata K, Hashimoto T, and Gonzalez FJ. Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem 273: 5678-5684, 1998.
3. Atkinson LL, Fischer MA, and Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. J Biol Chem 277: 29424-29430, 2002.
4. Belke DD, Larsen TS, Lopaschuk GD, and Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. Am J Physiol Regul Integr Comp Physiol 277: R1210-R1217, 1999.
5. Bowker-Kinley MM, Davis WI, Wu P, Harris RA, and Popov KM. Evidence for existence of tissue-specific regulation of the mammalian pyruvate dehydrogenase complex. Biochem J 329: 191-196, 1998.
6. Brandt JM, Djouadi F, and Kelly DP. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor alpha. J Biol Chem 273: 23786-23792, 1998.
7. Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JR, Belke DD, Severson DL, Kelly DP, and Lopaschuk GD. A role for PPARα in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARα are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. J Biol Chem 4: 4, 2001.
8. Constantin-Teodosiu D, Cederblad G, and Hultman E. A sensitive radioisotopic assay of pyruvate dehydrogenase complex in human muscle tissue. Anal Biochem 198: 347-351, 1991.
9. Escher P and Wahli W. Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448: 121-138, 2000.
10. Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, and Kelly DP. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. J Clin Invest 109: 121-130, 2002.
11. Forman BM, Chen J, and Evans RM. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors alpha and delta. Proc Natl Acad Sci USA 94: 4312-4317, 1997.
12. Harris RA, Huang B, and Wu P. Control of pyruvate dehydrogenase kinase gene expression. Adv Enzyme Regul 41: 269-288, 2001.
13. Holness MJ, Smith ND, Bulmer K, Hopkins T, Gibbons GF, and Sugden MC. Evaluation of the role of peroxisome-proliferator-activated receptor alpha in the regulation of cardiac pyruvate dehydrogenase kinase 4 protein expression in response to starvation, high-fat feeding and hyperthyroidism. Biochem J 364: 687-694, 2002.
14. Hucho F, Randall DD, Roche TE, Burgett MW, Pelley JW, and Reed LJ. α-Keto acid dehydrogenase complexes. XVII. Kinetic and regulatory properties of pyruvate dehydrogenase kinase and pyruvate dehydrogenase phosphatase from bovine kidney and heart. Arch Biochem Biophys 151: 328-340, 1972.
15. Issemann I and Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347: 645-650, 1990.
16. Kantor PF, Lopaschuk G, and Opie LH. Myocardial energy metabolism. In: Heart Physiology and Pathophysiology (4th ed.). New York: Academic, 2001, p. 543-569.
17. Lock EA, Mitchell AM, and Elcombe CR. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu Rev Pharmacol Toxicol 29: 145-163, 1989.
18. Mascaro C, Acosta E, Ortiz JA, Marrero PF, Hegardt FG, and Haro D. Control of human muscle-type carnitine palmitoyltransferase I gene transcription by peroxisome proliferator-activated receptor. J Biol Chem 273: 8560-8563, 1998.
19. Patel MS and Roche TE. Molecular biology and biochemistry of pyruvate dehydrogenase complexes. FASEB J 4: 3224-3233, 1990.
20. Pratt ML and Roche TE. Mechanism of pyruvate inhibition of kidney pyruvate dehydrogenasea kinase and synergistic inhibition by pyruvate and ADP. J Biol Chem 254: 7191-7196, 1979.
21. Randle PJ, Ascuitto RJ, Ross-Ascuitto NT, Chen V, and Downing SE. Fuel selection in animals. Biochem Soc Trans 14: 799-806, 1986.
22. Randle PJ, Garland PB, Hales CN, Newsholme EA, Denton RM, and Pogson CI. Interactions of metabolism and the physiological role of insulin. Recent Prog Horm Res 22: 1-48, 1966.
23. Saddik M and Lopaschuk GD. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts. J Biol Chem 266: 8162-8170, 1991.
24. Sugden MC, Bulmer K, Gibbons GF, and Holness MJ. Role of peroxisome proliferator-activated receptor-alpha in the mechanism underlying changes in renal pyruvate dehydrogenase kinase isoform 4 protein expression in starvation and after refeeding. Arch Biochem Biophys 395: 246-252, 2001.
25. Sugden MC, Fryer LG, Orfali KA, Priestman DA, Donald E, and Holness MJ. Studies of the long-term regulation of hepatic pyruvate dehydrogenase kinase. Biochem J 329: 89-94, 1998.
26. Sugden MC, Langdown ML, Harris RA, and Holness MJ. Expression and regulation of pyruvate dehydrogenase kinase isoforms in the developing rat heart and in adulthood: role of thyroid hormone status and lipid supply. Biochem J 352: 731-738, 2000.
27. Wu P, Blair PV, Sato J, Jaskiewicz J, Popov KM, and Harris RA. Starvation increases the amount of pyruvate dehydrogenase kinase in several mammalian tissues. Arch Biochem Biophys 381: 1-7, 2000.
28. Wu P, Inskeep K, Bowker-Kinley MM, Popov KM, and Harris RA. Mechanism responsible for inactivation of skeletal muscle pyruvate dehydrogenase complex in starvation and diabetes. Diabetes 48: 1593-1599, 1999.
29. Wu P, Peters JM, and Harris RA. Adaptive increase in pyruvate dehydrogenase kinase 4 during starvation is mediated by peroxisome proliferator-activated receptor alpha. Biochem Biophys Res Commun 287: 391-396, 2001.
30. Wu P, Sato J, Zhao Y, Jaskiewicz J, Popov KM, and Harris RA. Starvation and diabetes increase the amount of pyruvate dehydrogenase kinase isoenzyme 4 in rat heart. Biochem J 329: 197-201, 1998.
31. Young ME, Patil S, Ying J, Depre C, Ahuja HS, Shipley GL, Stepkowski SM, Davies PJ, and Taegtmeyer H. Uncoupling protein 3 transcription is regulated by peroxisome proliferator-activated receptor (alpha) in the adult rodent heart. FASEB J 15: 833-845, 2001.
32. Yu GS, Lu YC, and Gulick T. Co-regulation of tissue-specific alternative human carnitine palmitoyltransferase Ibeta gene promoters by fatty acid enzyme substrate. J Biol Chem 273: 32901-32909, 1998.